Vaccination

Moderna plans 100 million Covid vaccine doses in early 2021

Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.

Diseases, Conditions, Syndromes

Anti-vaccine bastion France warily eyes COVID shots

France was once home to the father of immunisation, Louis Pasteur, but it is now among the most vaccine-sceptic nations on Earth—a pressing concern as it prepares one of the biggest vaccination campaigns in its history.

Diseases, Conditions, Syndromes

After year-long sprint, Covid-19 vaccines finally at hand

Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release.

Medications

Simple new testing method aims to improve time-release drugs

When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug dissolves too slowly or too ...

Health

E. coli outbreak may be linked to recalled romaine lettuce

A link between an Escherichia coli outbreak that has sickened 12 people in six states and recalled romaine lettuce sold by Tanimura & Antle is being investigated by the U.S. Centers for Disease Control and Prevention.

Medical research

Silencing gene expression to cure complex diseases

Many people think of new medicines as bullets, and in the pharmaceutical industry, frequently used terms like "targets" and "hits" reinforce that idea. Immuneering co-founder and CEO Ben Zeskind '03, Ph.D. '06 prefers a different ...

page 2 from 40